Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J. epilepsy clin. neurophysiol ; 18(2): 53-56, 2012. ilus, tab
Artigo em Inglês | LILACS | ID: lil-658978

RESUMO

In this study we used proteomics approaches to obtain the protein profile of human epileptic hippocampi (N=6) and control hippocampi obtained from autopsy (N=6). We used two-dimensional gel electrophoresis (2-D) coupled to HPLC and Mass spectroscopy (MALDI-TOF) to identify proteins differentially expressed. Nine proteins were differentially expressed comparing the hippocampus of patients with the hippocampus of control. Proteins that were increased in the hippocampus of patients with TLE were: isoform 1 of serum albumin, HSP 70, dihydropyrimidinase-related protein 2, isoform 1 of myelin basic protein, proton ATPase catalytic subunit A, and dihydrolipoyllysine-residue acethyltransferase component of pyruvate dehydrogenase complex. The expression of isoform 3 of spectrin alpha chain (fodrin) was down-regulated while the proteins glutathione S-transferase P and the DJ-1 (PARK7) were detected only in the hippocampus of patients with TLE. Taken together, our results provide evidence supporting a direct link between metabolic disturb and oxidative damage related to pathophysiology of TLE. Besides, indicates biomarkers for further investigations as therapies targeted to epilepsy.


No presente estudo empregou-se o método de proteômica para obter a expressão diferencial de proteínas em hipocampo de pacientes com epilepsia do lobo temporal (ELT) (N=6) comparado a hipocampos controle obtidos por meio de autópsia (N=6). O estudo foi feito por meio de eletroforese bidimensional, acoplada a HPLC e espectroscopia de massa. As proteínas que tiveram expressão aumentada no hipocampo de pacientes com ELT foram: isoforma-1 da soroalbumina, HSP70, diidropirimidinase-2, isoforma-1 da proteína básica da mielina, subunidade catalítica A da próton ATPase, glutationa S-transferase P, proteína DJ-1 (PARK7), e resíduo diidropolilisina do componente acetil-transferase do complexo da piruvato desidrogenase. A expressão da isoforma-3 da cadeia alfa da espectrina (fodrina) foi menor no hipocampo de pacientes com epilepsia do lobo temporal e as proteínas glutationa S-transferase P e PARK7 foram detectadas somente no tecido epiléptico. Assim, nossos resultados trazem evidencias sobre a direta relação entre distúrbio metabólico e dano oxidativo na patofisiologia da ELT. Além disto, o estudo indica biomarcadores para futuras investigações como alvos terapêuticos para epilepsia.


Assuntos
Humanos , Biomarcadores , Epilepsia do Lobo Temporal , Hipocampo
2.
Mol Biochem Parasitol ; 180(1): 47-50, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21723329

RESUMO

Selenoproteins are characterized by the incorporation of at least one amino acid selenocysteine (Sec-U) encoded by in-frame UGA stop codons. These proteins, as well as the components of the Sec synthesis pathway, are present in members of the bacteria, archaea and eukaryote domains. Although not a ubiquitous pathway in all organisms, it was also identified in several protozoa, including the Kinetoplastida. Genetic evidence has indicated that the pathway is non-essential to the survival of Trypanosoma growing in non-stressed conditions. By analyzing the effects of RNA interference of the Trypanosoma brucei selenophosphate synthetase SPS2, we found a requirement under sub-optimal growth conditions. The present work shows that SPS2 is involved in oxidative stress protection of the parasite and its absence severely hampers the parasite survival in the presence of an oxidizing environment that results in an apoptotic-like phenotype and cell death.


Assuntos
Estresse Oxidativo , Fosfotransferases/metabolismo , Proteínas de Protozoários/metabolismo , Trypanosoma brucei brucei/enzimologia , Oxirredução , Fosfotransferases/genética , Proteínas de Protozoários/genética , Selênio/metabolismo , Trypanosoma brucei brucei/genética , Trypanosoma brucei brucei/metabolismo
3.
Parasitology ; 136(8): 813-21, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19490729

RESUMO

In this work we evaluated the ability of different types of antimicrobial peptides to promote permeabilization and growth inhibition of Acanthamoeba castellanii trophozoites, which cause eye keratitis. We used cationic alpha-helical peptides P5 and P6, corresponding to the N-terminus of the pore-forming protein from Triatoma infestans, a blood-sucking insect, and a beta-hairpin amphipathic molecule (gomesin), of the spider Acanthoscurria gomesiana haemocytes. A. castellanii permeabilization was obtained after 1 h incubation with micromolar concentrations of both types of peptides. While permeabilization induced by gomesin increased with longer incubations, P5 permeabilization did not increase with time and occurred at doses that are more toxic for SIRC cells. P5, however, at doses below the critical dose used to kill rabbit corneal cells was quite effective in promoting growth inhibition. Similarly, P5 was more effective when serine protease inhibitor was added simultaneously to the permeabilization assay. High performance chromatography followed by mass spectrometry analysis confirmed that, in contrast to gomesin, P5 is hydrolysed by A. castellanii culture supernatants. We conclude that the use of antimicrobial peptides to treat A. castellanii infections requires the search of more specific peptides that are resistant to proteolysis.


Assuntos
Acanthamoeba castellanii/efeitos dos fármacos , Peptídeos Catiônicos Antimicrobianos/farmacologia , Proteínas e Peptídeos Salivares/farmacologia , Ceratite por Acanthamoeba/tratamento farmacológico , Acanthamoeba castellanii/crescimento & desenvolvimento , Acanthamoeba castellanii/metabolismo , Animais , Peptídeos Catiônicos Antimicrobianos/síntese química , Aracnídeos/química , Linhagem Celular , Permeabilidade da Membrana Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Hemócitos/química , Estrutura Secundária de Proteína , Coelhos , Proteínas e Peptídeos Salivares/síntese química , Proteínas e Peptídeos Salivares/química , Inibidores de Serina Proteinase/farmacologia , Triatoma/química , Trofozoítos/efeitos dos fármacos , Trofozoítos/metabolismo
4.
Insect Biochem Mol Biol ; 32(9): 991-7, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12213235

RESUMO

This work describes the purification, gene cloning and expression of infestin, a thrombin inhibitor from midguts of Triatoma infestans. Infestin is located in the midgut and its purification was performed by anion-exchange and affinity chromatographies. The N-terminal sequence and the sequence of tryptic peptides were determined. Using RT-PCR, total RNA and infestin cDNA information, a DNA fragment was cloned which encodes a multi non-classical Kazal-type serine protease inhibitor. Isolated native infestin has two non-classical Kazal-type domains and shows an apparent molecular mass of 13 kDa, while its gene codes for a protein with four non-classical Kazal-type domains corresponding to an apparent molecular mass of 22 kDa. Two recombinant infestins, r-infestin 1-2 and r-infestin 1-4, were constructed using the vector pVT102U/alpha and expressed in S. cerevisiae. Native and r-infestin 1-2 showed very similar inhibitory activities towards thrombin and trypsin with dissociation constants of 43.5 and 25 pM for thrombin and 2.0 and 3.1 nM for trypsin, respectively. No other serine protease of the blood coagulation cascade was inhibited by the r-infestin 1-2. Surprisingly, r-infestin 1-4 inhibited not only thrombin and trypsin (K(i) of 0.8 and 5.2 nM, respectively), but also factor XIIa, factor Xa and plasmin (K(i) of 78 pM, 59.2 and 1.1 nM, respectively).


Assuntos
Proteínas de Insetos/genética , Inibidores de Serina Proteinase/genética , Trombina/antagonistas & inibidores , Triatoma/genética , Sequência de Aminoácidos , Animais , Doença de Chagas , Clonagem Molecular , Sistema Digestório , Expressão Gênica , Genes de Insetos , Proteínas de Insetos/metabolismo , Insetos Vetores , Dados de Sequência Molecular , Inibidores de Serina Proteinase/metabolismo
5.
Mol Biochem Parasitol ; 112(1): 79-90, 2001 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-11166389

RESUMO

In trypanosomes transcription occurs as large polycistronic units, with trans-splicing and polyadenylation generating each individual mRNA. There are no defined RNA polymerase II promoters and mRNA stabilisation is most likely the process controlling levels of differentially expressed mRNAs, since no selective modulation of gene activity has even been reported at the transcriptional level. Here, we show a large decrease in the transcription rates by RNA polymerases I and II when proliferative forms of Trypanosoma cruzi (epimastigotes and amastigotes) transform into non-proliferative and infective forms (trypomastigotes). We also show that these changes in transcription occur in parallel with modifications in the nuclear structure. While nuclei of proliferative forms are round, contain small amounts of peripheral heterochromatin and a large nucleolus, nuclei of trypomastigotes are elongated, the nucleolus disappears and the heterochromatin occupies most of the nuclear compartment. The decrease in the transcription parallels the nucleolus disassembly, as seen by the dispersion of nucleolar antigens. As T. cruzi cycles continuously through proliferative and infective forms, the molecular mechanisms involved in the control of nuclear organisation and chromatin remodelling can be revealed by this system.


Assuntos
Núcleo Celular/ultraestrutura , Doença de Chagas/parasitologia , Regulação da Expressão Gênica no Desenvolvimento , Transcrição Gênica , Trypanosoma cruzi/crescimento & desenvolvimento , Animais , Linhagem Celular , Meios de Cultura , Imunofluorescência , Immunoblotting , Estágios do Ciclo de Vida , Microscopia Eletrônica , RNA Polimerase I/genética , RNA Polimerase I/metabolismo , RNA Polimerase II/genética , RNA Polimerase II/metabolismo , Trypanosoma cruzi/genética , Trypanosoma cruzi/metabolismo
6.
Insect Biochem Mol Biol ; 31(4-5): 465-72, 2001 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-11222956

RESUMO

Salivary anticoagulant activities are widely distributed among hematophagous arthropods. Most of them are inhibitors of the serine proteases of the coagulation cascade. Here we show that the saliva of the exclusively hematophagous insect Triatoma infestans, an important vector in the transmission of Chagas' disease, contains an uncommon trypsin-like activity, triapsin. This novel enzyme was purified and characterized. It is a serine protease that is stored as a zymogen in the luminal content of the salivary glands D2. Triapsin is activated by trypsin treatment, or when the saliva is ejected during the insect bite. The enzyme was purified 300-fold from the released saliva by anion exchange chromatography in a HiTrap Q column, followed by chromatography in Phenyl-Superose, and Superdex HR75. The purified triapsin shows an apparent molecular mass of around 40 kDa in non-reduced SDS gels and in sieving chromatography, and 33 kDa in reduced SDS-gels. Its activity is lost after incubation with dithiothreitol indicating that cysteine bridges are essential for activity. Triapsin cleaves gelatin and synthetic substrates showing preference for arginine at P1 residues. The best p-nitroanilide substrate is isoleucyl-prolyl-arginine. It does not cleave bradykinin, angiotensin and other lysine containing substrates. The triapsin amidolytic activity against chromogenic substrates is similar to plasminogen activators, such as urokinase and tissue plasminogen activator. However, it does not activate plasminogen. The fact that triapsin is released at the bite in its active form suggests that it has a role in blood feeding.


Assuntos
Proteínas de Insetos/isolamento & purificação , Insetos Vetores/enzimologia , Saliva/enzimologia , Triatoma/enzimologia , Tripsina/isolamento & purificação , Animais , Sangue , Doença de Chagas/transmissão , Precursores Enzimáticos/metabolismo , Comportamento Alimentar , Mordeduras e Picadas de Insetos , Proteínas de Insetos/metabolismo , Ativadores de Plasminogênio/isolamento & purificação , Ativadores de Plasminogênio/metabolismo , Inibidores de Proteases/farmacologia , Especificidade por Substrato , Tripsina/metabolismo
8.
Arq Bras Cardiol ; 74(1): 39-46, 2000 Jan.
Artigo em Inglês, Português | MEDLINE | ID: mdl-10935291

RESUMO

OBJECTIVE: To determine the following parameters in the Brazilian State of São Paulo: 1) the percentage of deaths due to acute myocardial infarction (AMI) occurring in hospitals; 2) the percentage of deaths due to AMI occurring in public health system hospitals as compared with all in-hospital deaths due to AMI between 1979 and 1996; 3) the fatality due to AMI in public health system hospitals from 1984 to 1998. METHODS: Data were available on the Datasus Web site (the health information agency of the Brazilian Department of Health) that provided the following: a) number of deaths resulting from AMI in hospitals; b) number of deaths resulting from AMI in public health system hospitals; c) number of hospital admissions due to AMI in public health system hospitals. RESULTS: The percentage of in-hospital deaths due to AMI increased from 54.9 in 1979 to 68.6 in 1996. The percentage contribution of the public health system to total number of deaths due to AMI occurring in hospitals decreased from 22.9 in 1984 to 13.7 in 1996; fatality due to AMI occurring in public health system hospitals had an irregular evolution from 1984 to 1992 and showed a slight trend for increased frequency from 1993 to 1998. CONCLUSION: The percentage of in-hospital deaths due to AMI has been increasing. Deaths resulting from AMI in public health system hospitals have decreased when compared with the total number of deaths due to AMI in all hospitals. Fatality due to AMI in public health system hospitals did not decrease from 1992 to 1998.


Assuntos
Mortalidade Hospitalar , Hospitais Públicos/estatística & dados numéricos , Infarto do Miocárdio/mortalidade , Brasil/epidemiologia , Feminino , Humanos , Masculino
9.
Arq Bras Cardiol ; 74(1): 43-46, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10904279

RESUMO

OBJECTIVE: To determine the following parameters in the Brazilian State of São Paulo: 1) the percentage of deaths due to acute myocardial infarction (AMI) occurring in hospitals; 2) the percentage of deaths due to AMI occurring in public health system hospitals as compared with all in-hospital deaths due to AMI between 1979 and 1996; 3) the fatality due to AMI in public health system hospitals from 1984 to 1998. METHODS: Data were available on the Datasus Web site (the health information agency of the Brazilian Department of Health) that provided the following: a) number of deaths resulting from AMI in hospitals; b) number of deaths resulting from AMI in public health system hospitals; c) number of hospital admissions due to AMI in public health system hospitals. RESULTS: The percentage of in-hospital deaths due to AMI increased from 54.9 in 1979 to 68.6 in 1996. The percentage contribution of the public health system to total number of deaths due to AMI occurring in hospitals decreased from 22.9 in 1984 to 13.7 in 1996; fatality due to AMI occurring in public health system hospitals had an irregular evolution from 1984 to 1992 and showed a slight trend for increased frequency from 1993 to 1998. CONCLUSION: The percentage of in-hospital deaths due to AMI has been increasing. Deaths resulting from AMI in public health system hospitals have decreased when compared with the total number of deaths due to AMI in all hospitals. Fatality due to AMI in public health system hospitals did not decrease from 1992 to 1998.

10.
Arq Bras Cardiol ; 74(1): 39-46, 2000 Jan.
Artigo em Inglês, Português | MEDLINE | ID: mdl-10904519

RESUMO

OBJECTIVE: To determine the following parameters in the Brazilian State of Sao Paulo: 1) the percentage of deaths due to acute myocardial infarction (AMI) occurring in hospitals; 2) the percentage of deaths due to AMI occurring in public health system hospitals as compared with all in-hospital deaths due to AMI between 1979 and 1996; 3) the fatality due to AMI in public health system hospitals from 1984 to 1998. METHODS: Data were available on the Datasus Web site (the health information agency of the Brazilian Department of Health) that provided the following: a) number of deaths resulting from AMI in hospitals; b) number of deaths resulting from AMI in public health system hospitals; c) number of hospital admissions due to AMI in public health system hospitals. RESULTS: The percentage of in-hospital deaths due to AMI increased from 54.9 in 1979 to 68.6 in 1996. The percentage contribution of the public health system to total number of deaths due to AMI occurring in hospitals decreased from 22.9 in 1984 to 13.7 in 1996; fatality due to AMI occurring in public health system hospitals had an irregular evolution from 1984 to 1992 and showed a slight trend for increased frequency from 1993 to 1998. CONCLUSION: The percentage of in-hospital deaths due to AMI has been increasing. Deaths resulting from AMI in public health system hospitals have decreased when compared with the total number of deaths due to AMI in all hospitals. Fatality due to AMI in public health system hospitals did not decrease from 1992 to 1998.

11.
J Cell Sci ; 113 ( Pt 7): 1299-307, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10704380

RESUMO

In the presence of sialic acid donors Trypanosoma cruzi acquires up to 10(7) sialic acid residues on its surface, in a reaction catalyzed by its unique trans-sialidase. Most of these sialic acid residues are incorporated into mucin-like glycoproteins. To further understand the biological role of parasite sialylation, we have measured the amount of mucin in this parasite. We found that both epimastigote and trypomastigote forms have the same number of mucin molecules per surface area, although trypomastigotes have less than 10% of the amount of glycoinositol phospholipids, the other major surface glycoconjugate of T. cruzi. Based on the estimated surface area of each mucin, we calculated that these molecules form a coat covering the entire trypomastigote cell. The presence of the surface coat is shown by transmission electron microscopy of Ruthenium Red-stained parasites. The coat was revealed by binding of antibodies isolated from Chagasic patients that react with high affinity to alpha-galactosyl epitopes present in the mucin molecule. When added to the trypomastigote, these antibodies cause an extensive structural perturbation of the parasite coat with formation of large blebs, ultimately leading to parasite lysis. Interestingly, lysis is decreased if the mucin coat is heavily sialylated. Furthermore, addition of MgCl2 reverses the protective effect of sialylation, suggesting that the sialic acid negative charges stabilize the surface coat. Inhibition of sialylation by anti-trans-sialidase antibodies, found in immunized animals, or human Chagasic sera, also increase killing by anti-alpha-galactosyl antibodies. Therefore, the large amounts of sialylated mucins, forming a surface coat on infective trypomastigote forms, have an important structural and protective role.


Assuntos
Anticorpos Antiprotozoários/toxicidade , Antígenos de Protozoários/imunologia , Mucinas/fisiologia , Trissacarídeos/imunologia , Trypanosoma cruzi/crescimento & desenvolvimento , Trypanosoma cruzi/imunologia , Animais , Doença de Chagas/imunologia , Doença de Chagas/parasitologia , Glicosilfosfatidilinositóis/metabolismo , Humanos , Imunidade Inata , Mucinas/metabolismo , Mucinas/ultraestrutura , Ácido N-Acetilneuramínico/metabolismo , Propriedades de Superfície , Trypanosoma cruzi/metabolismo , Trypanosoma cruzi/ultraestrutura
12.
Sao Paulo Med J ; 117(1): 25-33, 1999 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-10413968

RESUMO

CONTEXT: The drawing up of adequate Public Health action planning to address the true needs of the population would increase the chances of effectiveness and decrease unnecessary expenses. OBJECTIVE: To identify homogeneous regions in the UNIFESP/EPM healthcare center (HCC) coverage area based on sociodemographic indicators and to relate them to causes of deaths in 1995. DESIGN: Secondary data analysis. SETTING: HCC coverage area; primary care. SAMPLE: Sociodemographic indicators were obtained from special tabulations of the Demographic Census of 1991. MAIN MEASURES: Proportion of children and elderly in the population; family providers' education level (maximum: > 15 years, minimum: < 1 year) and income level (maximum: > 20 minimum wages, minimum: < 1 minimum wage); proportional mortality distribution RESULTS: The maximum income permitted the construction of four homogeneous regions, according to income ranking. Although the proportion of children and of elderly did not vary significantly among the regions, minimum income and education showed a statistically significant (p < 0.05) difference between the first region (least affluent) and the others. A clear trend of increasing maximum education was observed across the regions. Mortality also differed in the first region, with deaths generated by possibly preventable infections. CONCLUSION: The inequalities observed may contribute to primary health prevention.


Assuntos
Área Programática de Saúde/estatística & dados numéricos , Causas de Morte , Indicadores Básicos de Saúde , Atenção Primária à Saúde/estatística & dados numéricos , Idoso , Brasil/epidemiologia , Censos , Pré-Escolar , Demografia , Humanos , Renda/classificação , Lactente , Recém-Nascido , Pessoa de Meia-Idade , Fatores Socioeconômicos
13.
Nucleic Acids Res ; 27(12): 2451-6, 1999 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-10352173

RESUMO

Here we describe the cloning and characterisation of the Trypanosoma cruzi telomere. In the Y strain, it is formed by typical GGGTTA repeats with a mean size of approximately 500 bp. Adjacent to the telomere repeats we found a DNA sequence with significant homology to the T.cruzi 85 kDa surface antigen (gp85). Examination of the telomere in nine T.cruzi strains reveals differences in the organisation of chromosome ends. In one group of strains the size of the telomere repeat is relatively homogeneous and short (0.5-1.5 kb) as in the Y strain, while in the other, the length of the repeat is very heterogeneous and significantly longer, ranging in size from 1 to >10 kb. These different strains can be grouped similarly to previously existing classifications based on isoenzyme loci, rRNA genes, mini-exon gene sequences, randomly amplified polymorphic DNA and rRNA promoter sequences, suggesting that differential control of telomere length and organisation appeared as an early event in T. cruzi evolution. Two-dimensional pulsed field gel electrophoresis analysis shows that some chromosomes carry telomeres which are significantly larger than the mean telomere length. Importantly, the T.cruzi telomeres are organised in nucleosomal and non-nucleosomal chromatin.


Assuntos
DNA Topoisomerases Tipo I/isolamento & purificação , DNA de Protozoário/genética , Telômero/genética , Trypanosoma cruzi/genética , Animais , Cromatina , Cromossomos , Clonagem Molecular , DNA Topoisomerases Tipo I/metabolismo , Especificidade da Espécie , Trypanosoma cruzi/classificação
14.
Braz J Med Biol Res ; 32(2): 235-9, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10347760

RESUMO

Trypanosoma cruzi. the protozoan parasite that causes Chagas' disease, does not synthesize sialic acid, but expresses a trans-sialidase (TS) that catalyzes the transfer of sialic acid from host glycoconjugates to the parasite surface. Here, we review studies that characterize the immune response to the catalytic domain of the enzyme in humans during Chagas' disease or in mice following immunization with the TS gene. In both cases, there are antibodies that strongly inhibit the enzymatic activity and generation of interferon-gamma-producing T cells.


Assuntos
Doença de Chagas/imunologia , Neuraminidase/administração & dosagem , Trypanosoma cruzi/imunologia , Vacinas de DNA/administração & dosagem , Animais , Doença de Chagas/enzimologia , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Neuraminidase/imunologia
15.
J Biol Chem ; 274(19): 13041-7, 1999 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-10224055

RESUMO

To adapt to different environments, Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, expresses a different set of proteins during development. To begin to understand the mechanism that controls this differential gene expression, we have analyzed the levels of amastin and trans-sialidase mRNAs and the mRNAs encoding members of the 85-kDa glycoprotein gene family, which are differentially expressed in the T. cruzi stages found in the mammalian host. Amastin mRNA is expressed predominantly in intracellular and proliferative amastigotes. trans-Sialidase mRNAs are found mostly in forms undergoing transformation from amastigotes to trypomastigotes inside infected cells, whereas mRNAs encoding the 85-kDa glycoproteins appear only in the infective trypomastigotes released from the cells. The genes coding for these mRNA species are constitutively transcribed in all stages of T. cruzi cells, suggesting that expression is controlled post-transcriptionally during differentiation. Inhibition of transcription by actinomycin D revealed that each mRNA species has a relatively long half-life in stages where it accumulates. In the case of the trans-sialidase and 85-kDa glycoprotein genes, mRNA accumulation was induced by treatment with the protein synthesis inhibitor cycloheximide at the stages that preceded the normal accumulation. Therefore, mRNA stabilization may account for mRNA accumulation. mRNA degradation could be promoted by proteins with high turnover, or stabilization could be promoted by forming a complex with the translational machinery at defined times in development. Identification of the factors that induce mRNA degradation or stabilization is essential to the understanding of control of gene expression in these organisms.


Assuntos
Regulação da Expressão Gênica , Glicoproteínas/genética , Neuraminidase/genética , Processamento Pós-Transcricional do RNA , Trypanosoma cruzi/genética , Animais , Sequência de Bases , Cicloeximida/farmacologia , Primers do DNA , Dactinomicina/farmacologia , Inibidores da Síntese de Proteínas/farmacologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , RNA de Protozoário/genética , RNA de Protozoário/metabolismo , Transcrição Gênica/efeitos dos fármacos , Trypanosoma cruzi/enzimologia , Trypanosoma cruzi/metabolismo
16.
Parasite Immunol ; 21(2): 103-10, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10101720

RESUMO

Immunization with naked DNA represents an attractive strategy for development of vaccines against a variety of infections including those caused by protozoan parasites. Recently, we have described that immunization with a plasmid containing the trans-sialidase (TS) gene induced protective immunity against Trypanosoma cruzi infection in BALB/c mice. The present study was aimed at examining and comparing the effectiveness of immunization using either plasmid or recombinant delivered antigens in a mouse strain highly susceptible to infection (A/Sn). Two plasmids were generated containing the coding region for the catalytic domain of TS. TS gene was inserted into pcDNA3 vector with or without the coding region for TS signal peptide. These two plasmids were found to be equally immunogenic at inducing antibodies to TS or inhibition of T. cruzi infection. A third plasmid, in which the TS gene was inserted into the vector VR1012, was as immunogenic as the two others. Immunization with a TS recombinant protein in alum generated a significantly higher antibody response as measured by ELISA or inhibition of TS enzymatic activity. Most relevant, this immunization reduced the mortality due to acute infection.


Assuntos
Anticorpos Antiprotozoários/imunologia , Antígenos de Protozoários/imunologia , Doença de Chagas/imunologia , DNA de Protozoário/imunologia , Glicoproteínas/imunologia , Neuraminidase/imunologia , Vacinas Protozoárias/imunologia , Vacinas Sintéticas/imunologia , Animais , Antígenos de Protozoários/genética , Células COS , Doença de Chagas/parasitologia , Doença de Chagas/prevenção & controle , Glicoproteínas/genética , Imunoglobulina G/imunologia , Isotipos de Imunoglobulinas/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Neuraminidase/genética , Proteínas Recombinantes de Fusão/imunologia , Trypanosoma cruzi/imunologia , Vacinação
17.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;32(2): 235-9, feb. 1999. ilus, tab, graf
Artigo em Inglês | LILACS | ID: lil-228266

RESUMO

Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, does not synthesize sialic acid, but expresses a trans-sialidase (TS) that catalyzes the transfer of sialic acid from host glycoconjugates to the parasite surface. Here, we review studies that characterize the immune response to the catalytic domain of the enzyme in humans during Chagas' disease or in mice following immunization with the TS gene. In both cases, there are antibodies that strongly inhibit the enzymatic activity and generation of interferon-g-producing T cells


Assuntos
Humanos , Animais , Camundongos , Doença de Chagas/imunologia , Neuraminidase/imunologia , Trypanosoma cruzi/imunologia , Vacinas de DNA , Doença de Chagas/enzimologia , Camundongos Endogâmicos BALB C
19.
J Biol Chem ; 273(38): 24575-82, 1998 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-9733752

RESUMO

Sialidases (EC 3.2.1.18) are commonly found in viruses, bacteria, fungi, protozoa, and vertebrates, but not in invertebrates. We have previously reported the presence of a new sialidase activity in the gut of exclusively hematophagous insects of the Triatoma genus, which transmit Chagas' disease (Amino, R., Acosta, A., Morita, O. M., Chioccola, V. L. P., and Schenkman, S. (1995) Glycobiology 5, 625-631). Here we show that this sialidase is present in the salivary gland of Triatoma infestans, and it is released with the saliva during the insect bite. The sialidase was purified to homogeneity (>5000 times) to a specific activity of more than 20 units/mg. It elutes from a gel filtration column with a volume corresponding to the size of 33 kDa, and it migrates as a single 26-kDa band in SDS-polyacrylamide gel electrophoresis, which is unusually smaller when compared with other known sialidases. T. infestans sialidase hydrolyzes preferentially alpha2-->3-linked sialic acids at pH 4-8, with maximal activity between pH 5.5 and 6.5, which is compatible with the optimal pH of secreted sialidases. The sialidase is competitively inhibited by 2-deoxy-2, 3-dehydro-N-acetyl-neuraminic acid (Ki = 0.075 mM) and differently from many sialidases, with exception of Salmonella typhimurium sialidase, it is inhibited competitively by HEPES (Ki = 15 mM). The fact that T. infestans sialidase is released with the saliva and can hydrolyze sialyl-LewisX blood groups, which are the ligands for selectins, suggests that it might have a role in the blood feeding.


Assuntos
Mordeduras e Picadas de Insetos , Neuraminidase/metabolismo , Glândulas Salivares/enzimologia , Triatoma/enzimologia , Animais , Bactérias/enzimologia , Doença de Chagas/transmissão , Cromatografia em Gel , Cromatografia por Troca Iônica , Ingestão de Alimentos , Eletroforese em Gel de Poliacrilamida , HEPES/farmacologia , Cinética , Selectina L/metabolismo , Peso Molecular , Neuraminidase/isolamento & purificação , Selectina-P/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Especificidade por Substrato , Trypanosoma/enzimologia
20.
Mol Biochem Parasitol ; 93(1): 101-14, 1998 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-9662032

RESUMO

Sialic acid acceptors of Trypanosoma cruzi are abundant mucin-like glycoproteins linked to the parasite membrane by a glycosylphosphatidyl inositol (GPI) anchor. They are heterogeneous and variable in different parasite stages. The protein portion of these mucins contains many threonine residues, and is thought to be encoded by a heterogeneous gene family. To investigate whether the high degree of heterogeneity in the mucin gene family is responsible for the diversity of mucins expressed on the parasite surface, we have studied the expression of mucin genes in several developmental stages of T. cruzi. We have found that mucins are expressed in all parasite stages. By using conserved sequences at 3' end of translated sequences of the gene family and the splice leader sequence, we have isolated 120 mucin-like cDNAs by RT-PCR from epimastigote and trypomastigote mRNAs. All transcribed genes contain conserved 5' and 3' regions, which code for the signal peptide, the sequence for GPI anchor addition, and a conserved domain rich in threonine residues. The internal portions of these genes are highly variable in size and sequence, and can be grouped in two major categories. One group contains KP(1-2)T(6-8) repeats, a motif found in mammalian mucins in the central region. This group is expressed preferentially in the trypomastigote forms ready to be released from the infected mammalian cell. The other has highly variable sequences in the central portion, and is expressed in all parasite stages. Because the number of synonymous substitutions is equivalent to the non-synonymous substitutions in the second group, they are probably evolving neutrally. On the other hand, the KP(1-2)T(6-8) containing genes have more synonymous substitutions and are most likely under a strong selective pressure. We propose that the group of KP(1-2)T(6-8) motif corresponds to the highly glycosylated mucins of the trypomastigote stages. In the other group proteolysis may remove the central domain yielding small mucins, such as the mucins found in insect derived stages of T. cruzi.


Assuntos
Genes de Protozoários , Mucinas/genética , Família Multigênica , Trypanosoma cruzi/genética , Animais , Sequência de Bases , Diferenciação Celular/genética , Clonagem Molecular , Sequência Conservada , Cosmídeos , DNA Complementar/genética , Regulação da Expressão Gênica , Biblioteca Genômica , Funções Verossimilhança , Dados de Sequência Molecular , Mucinas/classificação , Sequências Repetitivas de Ácido Nucleico , Análise de Sequência de DNA , Transcrição Gênica , Trypanosoma cruzi/citologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA